Ownership
Private
Stage
Other
Preclinical
Phase 1
Phase 2
Phase 3
Approved

Celito Tech General Information

Celito Tech delivers advanced software platforms and consulting services to pharmaceutical, biotech, and medical device companies. Their solutions support clients throughout the entire product lifecycle—from early-stage development through commercialization—by digitizing clinical, quality, data/document management, compliance workflows, and executive IT strategy. The company has contributed to the launch of 10+ drugs across multiple client organizations by providing critical technology infrastructure but does not itself conduct clinical trials or own therapeutic assets.

Contact Information

Primary Industry
Biomedical IT and Biomedical Data Platforms
Corporate Office
Palo Alto, California
United States

Drug Pipeline

No pipeline data available

For full access to Celito Tech's pipeline data

Book a demo

Key Partnerships

Sarcomatrix Therapeutics – strategic collaboration to advance S‑969 into clinic using Helyx Platform for digital trial enablement

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Celito Tech Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Celito Tech's complete valuation and funding history, request access »

Celito Tech Financial Metrics